HMOX1 and metabolic dysfunction-associated steatotic liver disease: Some studies have also shown that crocetin is a potential bioactive component of saffron in the treatment of nonalcoholic fatty liver disease, and its mechanism of action includes inhibiting oxidative stress, alleviating inflammation, and upregulating the expression of Nrf2 and HO-1 [25].